Warning! GuruFocus detected
1 Severe warning sign
with SMTI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Sanara MedTech Inc
NAICS : 333314
SIC : 3843
ISIN : US98211X1063
Description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | -17.36 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.73 | |||||
| Beneish M-Score | -2.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 45.9 | |||||
| 3-Year EBITDA Growth Rate | 39.9 | |||||
| 3-Year EPS without NRI Growth Rate | -8.2 | |||||
| 3-Year FCF Growth Rate | 65.9 | |||||
| 3-Year Book Growth Rate | 4.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.63 | |||||
| 9-Day RSI | 43 | |||||
| 14-Day RSI | 43.59 | |||||
| 3-1 Month Momentum % | 4.49 | |||||
| 6-1 Month Momentum % | 14.72 | |||||
| 12-1 Month Momentum % | -6.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.18 | |||||
| Quick Ratio | 2 | |||||
| Cash Ratio | 1.04 | |||||
| Days Inventory | 163.87 | |||||
| Days Sales Outstanding | 43.63 | |||||
| Days Payable | 59.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.5 | |||||
| Shareholder Yield % | -5.83 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.61 | |||||
| Operating Margin % | -9.99 | |||||
| Net Margin % | -11.15 | |||||
| FCF Margin % | -0.29 | |||||
| ROE % | -23.12 | |||||
| ROA % | -12.24 | |||||
| ROIC % | -14.96 | |||||
| 3-Year ROIIC % | -2.82 | |||||
| ROC (Joel Greenblatt) % | -146.32 | |||||
| ROCE % | -10.37 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.01 | |||||
| PB Ratio | 6.75 | |||||
| EV-to-EBIT | -42.85 | |||||
| EV-to-EBITDA | -156.25 | |||||
| EV-to-Revenue | 3.35 | |||||
| EV-to-Forward-Revenue | 2.72 | |||||
| EV-to-FCF | -1144.2 | |||||
| Price-to-GF-Value | 0.53 | |||||
| Price-to-Median-PS-Value | 0.97 | |||||
| Earnings Yield (Greenblatt) % | -2.33 | |||||
| FCF Yield % | -0.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SMTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sanara MedTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 86.673 | ||
| EPS (TTM) ($) | -1.14 | ||
| Beta | 1.22 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 0.64 | ||
| Volatility % | 37.94 | ||
| 14-Day RSI | 43.59 | ||
| 14-Day ATR ($) | 1.796938 | ||
| 20-Day SMA ($) | 32.3155 | ||
| 12-1 Month Momentum % | -6.24 | ||
| 52-Week Range ($) | 26 - 39.08 | ||
| Shares Outstanding (Mil) | 8.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sanara MedTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sanara MedTech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sanara MedTech Inc Frequently Asked Questions
What is Sanara MedTech Inc(SMTI)'s stock price today?
The current price of SMTI is $30.37. The 52 week high of SMTI is $39.08 and 52 week low is $26.00.
When is next earnings date of Sanara MedTech Inc(SMTI)?
The next earnings date of Sanara MedTech Inc(SMTI) is 2025-05-13 Est..
Does Sanara MedTech Inc(SMTI) pay dividends? If so, how much?
Sanara MedTech Inc(SMTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers